Molecular Devices
Molecular Devices produces equipment and a host of related reagents and consumables for automation of biological researches and drug development.
Molecular Devices now offers the latest technologies for cell
screening and selection, , protein
science, high-content screening, automated electrophysiology, patch-clamp.
Molecular Devices capabilities include:
• Bacterial Colony Picking;
• Cell Viability Assessment;
• High-content screening
• Live Mammalian Cell Imaging;
• Mammalian Cell Clone Selection;
• Microarrays;
• Ion-channels and receptors analysis.
High content screening (HCS) is a combination of modern cell biology, automated high resolution microscopy, and robotic handling. The technology is mainly used to determine whether a potential drug affects aspects of cell function. The parallel acquisition of data specific to different cell properties, (for example, activity of signal transduction cascades and cytoskeleton integrity) is the main advantage of this method in comparison to high throughput screening. While high content screening is slower, the wealth of acquired data and the multi-parametric nature of those data allow a much more detailed understanding of drug effects on cell function. Molecular Devices provides a well-validated family of high content screening and analysis solutions, from automated systems with and without live cell options, to analysis and informatics software, to tools for data management in the field of bioanalytical, drug development, and life science research.